119th Congress · introduced in the House · Apr 21, 2025
Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.
Official title from Congress.gov
Latest action (Apr 21, 2025): Referred to the House Committee on Energy and Commerce.
View on Congress.govPolicy area: Health
No official summary has been published for this bill.
No cosponsors.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Energy and Commerce.
Submitted in House
Submitted in House
Actions from Congress.gov, newest first.
Cancer · Drug safety, medical device, and laboratory regulation · Food and Drug Administration (FDA) · Medical research · Prescription drugs · Research administration and funding · Sex and reproductive health · Women's health
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
No matching lobbying reports found within coverage